Follow
Lucas van den Hoogen
Lucas van den Hoogen
Radboudumc and St. Maartenskliniek, Nijmegen, The Netherlands
Verified email at radboudumc.nl
Title
Cited by
Cited by
Year
Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells
CA Dutertre, E Becht, SE Irac, A Khalilnezhad, V Narang, S Khalilnezhad, ...
Immunity 51 (3), 573-589. e8, 2019
3872019
Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity
D Koole, HJA Zandvoort, A Schoneveld, A Vink, JA Vos, ...
Journal of vascular surgery 57 (1), 77-83, 2013
1392013
Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome
M van der Linden, LL van den Hoogen, GHA Westerlaken, ...
Rheumatology 57 (7), 1228-1234, 2018
782018
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis
E Chouri, NH Servaas, CPJ Bekker, AJ Affandi, M Cossu, MR Hillen, ...
Journal of Autoimmunity 89, 162-170, 2018
772018
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome
LL van den Hoogen, JAG van Roon, JS Mertens, J Wienke, AP Lopes, ...
Annals of the rheumatic diseases 77 (12), 1810-1814, 2018
732018
Delineating the deranged immune system in the antiphospholipid syndrome
LL van den Hoogen, JAG van Roon, TRDJ Radstake, RDE Fritsch-Stork, ...
Autoimmunity reviews 15 (1), 50-60, 2016
682016
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use
LL van den Hoogen, RDE Fritsch-Stork, MA Versnel, RHWM Derksen, ...
Annals of the rheumatic diseases 75 (12), e81-e81, 2016
612016
Galectin‐9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation
J Wienke, F Bellutti Enders, J Lim, JS Mertens, LL van den Hoogen, ...
Arthritis & Rheumatology 71 (8), 1377-1390, 2019
602019
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome
M van der Kroef, LL van den Hoogen, JS Mertens, SLM Blokland, ...
European journal of immunology 50 (1), 119-129, 2020
422020
microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome
LL van den Hoogen, M Rossato, AP Lopes, A Pandit, CPJ Bekker, ...
Rheumatology 57 (9), 1669-1674, 2018
392018
Autoantibodies to cytosolic 5′-nucleotidase 1A in primary Sjögren’s syndrome and systemic lupus erythematosus
A Rietveld, LL Van Den Hoogen, N Bizzaro, SLM Blokland, JE Gottenberg, ...
Frontiers in Immunology 9, 333656, 2018
392018
Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren’s syndrome
SLM Blokland, LL van den Hoogen, EFA Leijten, SAY Hartgring, R Fritsch, ...
Rheumatology 58 (10), 1740-1745, 2019
322019
Aging and systemic lupus erythematosus-immunosenescence and beyond
L Laurens van den Hoogen, G Patrick Sims, J Adrianus Gijsbert van Roon, ...
Current Aging Science 8 (2), 158-177, 2015
312015
Low‐Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti–β2‐Glycoprotein I Antibodies: Comment on the Article by …
LL Van den Hoogen, RDE Fritsch‐Stork, JAG Van Roon, T Radstake
Arthritis & rheumatology 68 (5), 1320-1321, 2016
302016
Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus
HM Kok, LL van den Hoogen, JAG van Roon, EJM Adriaansen, ...
Rheumatology 56 (12), 2129-2134, 2017
292017
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome
LL van den Hoogen, M van der Linden, L Meyaard, RDE Fritsch-Stork, ...
Annals of the Rheumatic Diseases 79 (10), e135-e135, 2020
262020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk
J Wienke, JS Mertens, S Garcia, J Lim, CA Wijngaarde, JG Yeo, A Meyer, ...
Rheumatology 60 (2), 785-801, 2021
212021
The identification of CCL18 as biomarker of disease activity in localized scleroderma
JS Mertens, E de Jong, LL van Den Hoogen, J Wienke, RM Thurlings, ...
Journal of Autoimmunity 101, 86-93, 2019
202019
Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndrome
LL van den Hoogen, JM van Laar
Best Practice & Research Clinical Rheumatology 34 (1), 101485, 2020
192020
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid …
LL van den Hoogen, G Palla, CPJ Bekker, RDE Fritsch-Stork, ...
RMD open 4 (2), e000693, 2018
192018
The system can't perform the operation now. Try again later.
Articles 1–20